Interferon alpha-2b and thalidomide in previously treated patients with disseminated malignant melanoma: SWOG 0026.

被引：0
|
作者：
Hutchins, L
Moon, J
Clark, J
Thompson, J
Yost, K
Sondak, V
机构：
[1] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[2] SW Oncol Grp, Ctr Stat, Seattle, WA USA
[3] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Grand Rapids CCOP, Grand Rapids, MI USA
[6] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：716S / 716S
页数：1
相关论文
共 50 条
  • [21] A PROSPECTIVE TRIAL OF RECOMBINANT HUMAN INTERFERON ALPHA-2B IN PREVIOUSLY UNTREATED PATIENTS WITH HEPATOCELLULAR-CARCINOMA
    不详
    CANCER, 1990, 66 (01) : 135 - 139
  • [22] STUDIES OF VONWILLEBRAND-FACTOR IN ESSENTIAL THROMBOCYTHEMIA PATIENTS TREATED WITH ALPHA-2B RECOMBINANT INTERFERON
    MAZZUCCONI, MG
    FERRARI, A
    SOLINAS, S
    VITALE, A
    CHISTOLINI, A
    FEDERICI, AB
    MANDELLI, F
    HAEMOSTASIS, 1991, 21 (03) : 135 - 140
  • [23] Hepatic artery stenosis in liver transplanted patients treated with pegylated interferon alpha-2b and ribavirin
    Biselli, M
    Lorenzini, S
    Gramenzi, A
    Andreone, P
    Bernardi, M
    Rossi, C
    Grazi, GL
    TRANSPLANTATION, 2004, 78 (06) : 953 - 954
  • [24] A phase II trial of recombinant interferon alpha-2b and cisplatin in metastatic melanoma
    Bække, J
    Rytter, C
    Mouridsen, H
    Madsen, EL
    Moholt, K
    Bastholt, L
    ACTA ONCOLOGICA, 2000, 39 (05) : 625 - 628
  • [25] Treatment of three patients with systemic mastocytosis with interferon alpha-2b
    Worobec, AS
    Kirshenbaum, AS
    Schwartz, LB
    Metcalfe, DD
    LEUKEMIA & LYMPHOMA, 1996, 22 (5-6) : 501 - 508
  • [26] Toxicity and feasibility of adjuvant high dose interferon alpha-2b in patients with melanoma in clinical oncologic practice
    Ravaud, A
    Bedane, C
    Geoffrois, L
    Lesimple, T
    Delaunay, M
    BRITISH JOURNAL OF CANCER, 1999, 80 (11) : 1767 - 1769
  • [27] Resolution of hepatitis B viremia in a renal transplant recipient treated with alpha-2b interferon
    Post, AB
    Hricik, DE
    Sterling, RK
    Bartucci, MR
    Jacobs, GH
    Schulak, JA
    NEPHRON, 1998, 79 (04): : 469 - 471
  • [28] Widespread Ocular Surface Squamous Neoplasia Treated with Topical Interferon Alpha-2b
    Patel, Hershel
    Jeang, Lauren J.
    Shah, Ankit
    Espana, Edgar M.
    Margo, Curtis E.
    OCULAR ONCOLOGY AND PATHOLOGY, 2018, 4 (05) : 298 - 303
  • [29] Comparison of the Efficacy and Safety of Pegylated Interferon Alpha-2b and Common Interferon Alpha in Patients with Myeloproliferative Neoplasms
    Teng, Guangshuai
    Zhang, Yuhui
    Du, Chenxiao
    Wang, Yan
    Hu, Naibo
    Han, Yingdi
    Ma, Jinyu
    Gao, Shan
    Xiang, Guangpeng
    Shao, Zonghong
    Bai, Jie
    BLOOD, 2022, 140 : 3959 - 3960
  • [30] Hepatitis C viral kinetics treated with ribavirin and interferon alpha-2b in patients with normal transaminases.
    Pena, R
    Munoz, S
    Suvannasankha, A
    DiGregorio, K
    Stein, L
    Gross, F
    Peikin, S
    Perez, O
    Benson, G
    Mushnick, A
    DeAngelo, C
    Goldfarb, J
    Rothstein, K
    Manzarbeitia, C
    Reich, D
    Kern, N
    HEPATOLOGY, 1998, 28 (04) : 286A - 286A
12345